GHRP-2 and Retatrutide Interaction

Monitor
Mechanism-based 47% confidence

GHRP-2 and Retatrutide have an interaction requiring monitoring for interaction with 47% confidence. Both GHRP-2 and Retatrutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

GHRP-2

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.

Half-life: ~30 minutes Typical dose: 100-300 mcg growth hormone, weight loss
ghrelin receptor carcinogenic riskinsulin disruptingprolactin elevatingteratogenic
View full profile

Retatrutide

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

Activates GLP-1 for appetite suppression, GIP for insulin sensitivity, and glucagon for increased energy expenditure and hepatic fat oxidation..

Half-life: ~6 days Typical dose: 0.5mg starting, titrate up to 8-12mg weekly weight loss, metabolic
insulin disrupting
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (GHRP-2, Retatrutide). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take GHRP-2 with Retatrutide?

Yes, but with caution. Both GHRP-2 and Retatrutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is GHRP-2 and Retatrutide safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between GHRP-2 and Retatrutide?

Both GHRP-2 and Retatrutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time GHRP-2 and Retatrutide?

GHRP-2 has a half-life of ~30 minutes and Retatrutide has a half-life of ~6 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: GHRP-2 vs Retatrutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.